UpdatesGeneral Updates
RPG Life Sciences' subsidiary approved acquiring Raghava Life Sciences' API & intermediates business as a slump sale for up to 135 Cr.
RPG Life Sciences LimitedRPGLIFE · Filed with the exchange
This expands RPG's API footprint, adding manufacturing, R&D, and 29 molecules.
The acquired business generated 19 Cr revenue in FY26.
No comments yet. Be the first.